4
Changes in Ownership
Nuvectis Pharma, Inc. Filed Acc 0001104659-22-059890
Chief Dev. & Ops. Officer bought 1,278 shares at an average $15.85 ($20,255)
From the SEC's structured data for this filing
Trades in this filing
Shemesh Shay · Chief Dev. & Ops. Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-05-12 | Purchase : show line 1 in the form | +36 | $14.58 | $525 | 1,239,651 | D |
| 2022-05-12 | Purchase : show line 2 in the form | +1,184 | $15.85 | $18,766 | 1,240,835 | D |
| 2022-05-12 | Purchase : show line 3 in the form | +58 | $16.61 | $963 | 1,240,893 | D |
| Open-market purchases · 1,278 sh · avg $15.85 · $20,255 | ||||||
Loading xslF345X03/tm2215423-5_4seq1.xml…